CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
Over half of breast-cancer-related deaths are due to recurrence 5 or more years after initial diagnosis and treatment. This latency suggests that a population of residual tumor cells can survive treatment and persist in a dormant state for many years. The role of the microenvironment in regulating t...
Main Authors: | Andrea Walens, Ashley V DiMarco, Ryan Lupo, Benjamin R Kroger, Jeffrey S Damrauer, James V Alvarez |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2019-04-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/43653 |
Similar Items
-
Mas receptor activation attenuates allergic airway inflammation via inhibiting JNK/CCL2-induced macrophage recruitment
by: Luna Hong, et al.
Published: (2021-05-01) -
Stromal CCL2 Signaling Promotes Mammary Tumor Fibrosis through Recruitment of Myeloid-Lineage Cells
by: Genevra Kuziel, et al.
Published: (2020-07-01) -
Spi-B Promotes the Recruitment of Tumor-Associated Macrophages via Enhancing CCL4 Expression in Lung Cancer
by: Qiumin Huang, et al.
Published: (2021-06-01) -
Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis
by: Xiufang Kong, et al.
Published: (2021-05-01) -
Radiotherapy Increases 12-LOX and CCL5 Levels in Esophageal Cancer Cells and Promotes Cancer Metastasis via THP-1-Derived Macrophages
by: Mi S, et al.
Published: (2020-08-01)